The Beta-2-Adrenoreceptor Agonists, Formoterol and Indacaterol, but Not Salbutamol, Effectively Suppress the Reactivity of Human Neutrophils In Vitro
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2014-01-01
|
| Series: | Mediators of Inflammation |
| Online Access: | http://dx.doi.org/10.1155/2014/105420 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850224754324144128 |
|---|---|
| author | Ronald Anderson Annette J. Theron Helen C. Steel Chrisna Durandt Gregory R. Tintinger Charles Feldman |
| author_facet | Ronald Anderson Annette J. Theron Helen C. Steel Chrisna Durandt Gregory R. Tintinger Charles Feldman |
| author_sort | Ronald Anderson |
| collection | DOAJ |
| format | Article |
| id | doaj-art-533b141e8edf4986b53f68dd9fd08a2d |
| institution | OA Journals |
| issn | 0962-9351 1466-1861 |
| language | English |
| publishDate | 2014-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Mediators of Inflammation |
| spelling | doaj-art-533b141e8edf4986b53f68dd9fd08a2d2025-08-20T02:05:32ZengWileyMediators of Inflammation0962-93511466-18612014-01-01201410.1155/2014/105420105420The Beta-2-Adrenoreceptor Agonists, Formoterol and Indacaterol, but Not Salbutamol, Effectively Suppress the Reactivity of Human Neutrophils In VitroRonald Anderson0Annette J. Theron1Helen C. Steel2Chrisna Durandt3Gregory R. Tintinger4Charles Feldman5Medical Research Council Unit for Inflammation and Immunity, Department of Immunology, Faculty of Health Sciences, University of Pretoria, P.O. Box 2034, Pretoria 0001, South AfricaMedical Research Council Unit for Inflammation and Immunity, Department of Immunology, Faculty of Health Sciences, University of Pretoria, P.O. Box 2034, Pretoria 0001, South AfricaMedical Research Council Unit for Inflammation and Immunity, Department of Immunology, Faculty of Health Sciences, University of Pretoria, P.O. Box 2034, Pretoria 0001, South AfricaMedical Research Council Unit for Inflammation and Immunity, Department of Immunology, Faculty of Health Sciences, University of Pretoria, P.O. Box 2034, Pretoria 0001, South AfricaMedical Research Council Unit for Inflammation and Immunity, Department of Immunology, Faculty of Health Sciences, University of Pretoria, P.O. Box 2034, Pretoria 0001, South AfricaDivision of Pulmonology, Department of Internal Medicine, Faculty of Health Sciences, University of the Witwatersrand and Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg 2193, South Africahttp://dx.doi.org/10.1155/2014/105420 |
| spellingShingle | Ronald Anderson Annette J. Theron Helen C. Steel Chrisna Durandt Gregory R. Tintinger Charles Feldman The Beta-2-Adrenoreceptor Agonists, Formoterol and Indacaterol, but Not Salbutamol, Effectively Suppress the Reactivity of Human Neutrophils In Vitro Mediators of Inflammation |
| title | The Beta-2-Adrenoreceptor Agonists, Formoterol and Indacaterol, but Not Salbutamol, Effectively Suppress the Reactivity of Human Neutrophils In Vitro |
| title_full | The Beta-2-Adrenoreceptor Agonists, Formoterol and Indacaterol, but Not Salbutamol, Effectively Suppress the Reactivity of Human Neutrophils In Vitro |
| title_fullStr | The Beta-2-Adrenoreceptor Agonists, Formoterol and Indacaterol, but Not Salbutamol, Effectively Suppress the Reactivity of Human Neutrophils In Vitro |
| title_full_unstemmed | The Beta-2-Adrenoreceptor Agonists, Formoterol and Indacaterol, but Not Salbutamol, Effectively Suppress the Reactivity of Human Neutrophils In Vitro |
| title_short | The Beta-2-Adrenoreceptor Agonists, Formoterol and Indacaterol, but Not Salbutamol, Effectively Suppress the Reactivity of Human Neutrophils In Vitro |
| title_sort | beta 2 adrenoreceptor agonists formoterol and indacaterol but not salbutamol effectively suppress the reactivity of human neutrophils in vitro |
| url | http://dx.doi.org/10.1155/2014/105420 |
| work_keys_str_mv | AT ronaldanderson thebeta2adrenoreceptoragonistsformoterolandindacaterolbutnotsalbutamoleffectivelysuppressthereactivityofhumanneutrophilsinvitro AT annettejtheron thebeta2adrenoreceptoragonistsformoterolandindacaterolbutnotsalbutamoleffectivelysuppressthereactivityofhumanneutrophilsinvitro AT helencsteel thebeta2adrenoreceptoragonistsformoterolandindacaterolbutnotsalbutamoleffectivelysuppressthereactivityofhumanneutrophilsinvitro AT chrisnadurandt thebeta2adrenoreceptoragonistsformoterolandindacaterolbutnotsalbutamoleffectivelysuppressthereactivityofhumanneutrophilsinvitro AT gregoryrtintinger thebeta2adrenoreceptoragonistsformoterolandindacaterolbutnotsalbutamoleffectivelysuppressthereactivityofhumanneutrophilsinvitro AT charlesfeldman thebeta2adrenoreceptoragonistsformoterolandindacaterolbutnotsalbutamoleffectivelysuppressthereactivityofhumanneutrophilsinvitro AT ronaldanderson beta2adrenoreceptoragonistsformoterolandindacaterolbutnotsalbutamoleffectivelysuppressthereactivityofhumanneutrophilsinvitro AT annettejtheron beta2adrenoreceptoragonistsformoterolandindacaterolbutnotsalbutamoleffectivelysuppressthereactivityofhumanneutrophilsinvitro AT helencsteel beta2adrenoreceptoragonistsformoterolandindacaterolbutnotsalbutamoleffectivelysuppressthereactivityofhumanneutrophilsinvitro AT chrisnadurandt beta2adrenoreceptoragonistsformoterolandindacaterolbutnotsalbutamoleffectivelysuppressthereactivityofhumanneutrophilsinvitro AT gregoryrtintinger beta2adrenoreceptoragonistsformoterolandindacaterolbutnotsalbutamoleffectivelysuppressthereactivityofhumanneutrophilsinvitro AT charlesfeldman beta2adrenoreceptoragonistsformoterolandindacaterolbutnotsalbutamoleffectivelysuppressthereactivityofhumanneutrophilsinvitro |